Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
Harmony Biosciences Holdings, Inc.
| Metric | Harmony Biosciences Holdings, Inc. HRMYHealthcare |
|---|---|
| Quality Score | 87 / 100 |
| Revenue (latest) | $868M |
| Net income (latest) | $159M |
| Operating margin | 24.0% |
| Net margin | 18.3% |
| Return on equity | 18.2% |
| Return on assets | 12.5% |
| Return on capital (ROCE) | 20.4% |
| Debt / equity | 0.46× |
| Revenue growth (YoY) | 21.5% |
| Altman Z″ (distress) | 7.17 |
| Accruals / assets | −14.9% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.